サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434960

不整脈市場：発生部位別、心房、検査機器-世界予測2024-2030年

Arrhythmia Market by Site Of Origin Atrial (Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia), Test Equipment (Electrocardiogram, Holter Monitor) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
不整脈市場：発生部位別、心房、検査機器-世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

不整脈市場規模は2023年に60億1,000万米ドルと推計され、2024年には64億8,000万米ドルに達し、CAGR 7.97%で2030年には102億9,000万米ドルに達すると予測されます。

不整脈の世界市場

主な市場の統計
基準年[2023］ 60億1,000万米ドル
予測年[2024］ 64億8,000万米ドル
予測年 [2030] 102億9,000万米ドル
CAGR（%） 7.97%
不整脈 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは不整脈市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、不整脈市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-不整脈市場の市場規模および予測は？

2-不整脈市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-不整脈市場における技術動向と規制の枠組みは？

4-不整脈市場における主要ベンダーの市場シェアは？

5-不整脈市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 国民の間で不整脈の普及率が増加し、不整脈監視デバイスの必要性が高まっている
      • 灌流式高周波（RF）アブレーションカテーテルデバイスの傾向
      • 不整脈の意識向上キャンペーン
    • 抑制要因
      • 不整脈の治療と機器に関連する高額な費用
    • 機会
      • 不整脈デバイスの技術の進歩
      • 新しい不整脈治療法を開発するための強力な調査活動
    • 課題
      • 不整脈モニタリングのためのホルター記録の制限
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 不整脈市場発生部位心房別

  • 心房頻脈
  • 心房期外収縮
  • 洞性徐脈
  • 徘徊心房ペースメーカー

第7章 不整脈市場試験装置別

  • 心電図
  • ホルター心電図

第8章 南北アメリカの不整脈市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の不整脈市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの不整脈市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • ACS Diagnostics
    • AliveCor, Inc.
    • AtriCure Inc.
    • Biotricity
    • BIOTRONIK, Inc.
    • Boston Scientific Corporation
    • CardioFocus, Inc.
    • CathRx Ltd.
    • Fukuda Denshi
    • GE Healthcare
    • GlaxoSmithKline PLC
    • Hill-Rom Holdings, Inc
    • iRhythm Technologies Inc.
    • Koninklijke Philips NV
    • Medi-Lynx Cardiac Monitoring, LLC
    • Medtronic PLC
    • MicroPort Scientific Corporation
    • Nihon Kohden Corporation
    • Novartis AG
    • OSI Systems, Inc.
    • Sanofi S.A.
    • SCHILLER
    • Siemens Healthcare GmbH
    • St. Jude Medical, Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ARRHYTHMIA MARKET RESEARCH PROCESS
  • FIGURE 2. ARRHYTHMIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARRHYTHMIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARRHYTHMIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARRHYTHMIA MARKET DYNAMICS
  • FIGURE 7. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2030 (%)
  • FIGURE 8. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2030 (%)
  • FIGURE 10. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARRHYTHMIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 6. ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 11. ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ARRHYTHMIA MARKET LICENSE & PRICING
目次
Product Code: MRR-A26E0E574313

[188 Pages Report] The Arrhythmia Market size was estimated at USD 6.01 billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 7.97% to reach USD 10.29 billion by 2030.

Global Arrhythmia Market

KEY MARKET STATISTICS
Base Year [2023] USD 6.01 billion
Estimated Year [2024] USD 6.48 billion
Forecast Year [2030] USD 10.29 billion
CAGR (%) 7.97%
Arrhythmia Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Arrhythmia Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Arrhythmia Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Arrhythmia Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, AliveCor, Inc., AtriCure Inc., Biotricity, BIOTRONIK, Inc., Boston Scientific Corporation, CardioFocus, Inc., CathRx Ltd., Fukuda Denshi, GE Healthcare, GlaxoSmithKline PLC, Hill-Rom Holdings, Inc, iRhythm Technologies Inc., Koninklijke Philips NV, Medi-Lynx Cardiac Monitoring, LLC, Medtronic PLC, MicroPort Scientific Corporation, Nihon Kohden Corporation, Novartis AG, OSI Systems, Inc., Sanofi S.A., SCHILLER, Siemens Healthcare GmbH, and St. Jude Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Arrhythmia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Site Of Origin Atrial
    • Atrial Tachycardia
    • Premature Atrial Contractions
    • Sinus Bradycardia
    • Wandering Atrial Pacemaker
  • Test Equipment
    • Electrocardiogram
    • Holter Monitor
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Arrhythmia Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Arrhythmia Market?

3. What are the technology trends and regulatory frameworks in the Arrhythmia Market?

4. What is the market share of the leading vendors in the Arrhythmia Market?

5. Which modes and strategic moves are suitable for entering the Arrhythmia Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Arrhythmia Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
      • 5.1.1.2. Trend of irrigated radiofrequency (RF) ablation catheter devices
      • 5.1.1.3. Rising awareness campaigns for arrhythmia
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost associated with arrhythmia treatment and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in arrhythmia devices
      • 5.1.3.2. Robust research activities to develop new arrhythmia treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation of holter recordings for arrhythmia monitoring
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Arrhythmia Market, by Site Of Origin Atrial

  • 6.1. Introduction
  • 6.2. Atrial Tachycardia
  • 6.3. Premature Atrial Contractions
  • 6.4. Sinus Bradycardia
  • 6.5. Wandering Atrial Pacemaker

7. Arrhythmia Market, by Test Equipment

  • 7.1. Introduction
  • 7.2. Electrocardiogram
  • 7.3. Holter Monitor

8. Americas Arrhythmia Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Arrhythmia Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Arrhythmia Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. ACS Diagnostics
    • 12.1.3. AliveCor, Inc.
    • 12.1.4. AtriCure Inc.
    • 12.1.5. Biotricity
    • 12.1.6. BIOTRONIK, Inc.
    • 12.1.7. Boston Scientific Corporation
    • 12.1.8. CardioFocus, Inc.
    • 12.1.9. CathRx Ltd.
    • 12.1.10. Fukuda Denshi
    • 12.1.11. GE Healthcare
    • 12.1.12. GlaxoSmithKline PLC
    • 12.1.13. Hill-Rom Holdings, Inc
    • 12.1.14. iRhythm Technologies Inc.
    • 12.1.15. Koninklijke Philips NV
    • 12.1.16. Medi-Lynx Cardiac Monitoring, LLC
    • 12.1.17. Medtronic PLC
    • 12.1.18. MicroPort Scientific Corporation
    • 12.1.19. Nihon Kohden Corporation
    • 12.1.20. Novartis AG
    • 12.1.21. OSI Systems, Inc.
    • 12.1.22. Sanofi S.A.
    • 12.1.23. SCHILLER
    • 12.1.24. Siemens Healthcare GmbH
    • 12.1.25. St. Jude Medical, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing